Pinned Tweet
Next #Innovation in intravascular imaging. #UKSH in Kiel the brand new Dragonfly OpStar #OCT Catheter. Without predilatation through tight stenosis. Optimizing #Fantom BRS implantation. @AGIKinterv @m_leistner @tommasoggori @HolgerNef @revamedicalinc
9
Matthias Lutz retweeted
In the FANTOM II study, the Fantom bioresorbable scaffolds (BRS), featuring a novel polymer and reduced strut thickness, demonstrated low 5-year rates of MACE and scaffold thrombosis, and favorable healing patterns at 24 months. These results, along with the modest late lumen loss (LLL) and low rate of binary restenosis observed, suggest the Fantom BRS as a safe and effective alternative to first-generation BRS and DES for patients with stable coronary artery disease and non-complex lesions. @MJLutz
ow.ly/1eVJ50R9MHI
Matthias Lutz retweeted
#AGIKwebPCI live und (teilweise) in Farbe (und bisschen schwarzweiss)
➡️ComplexNonCulpritPCI⬅️
🗓️07.03.204 I 18:00 CET
🔗 agikweb.dgk.org/livestream/
#WIRsindAGIK @AGIKinterv
Matthias Lutz retweeted
Very proud of this publication. Thanks to @LNAndreasen @omeedneghabat @h_evald @DrPeterOKane @jcspratt @SimoneBiscaglia @BURZOTTA_F @odenstedt @ThueOlsen @AUHCardio @AUHdk @AarhusUni
Results of OCTOBER trial presented at #ESCCongress:
In patients with coronary bifurcation lesions, PCI with optical coherence tomography guidance was associated with a lower incidence of major adverse cardiac events at a median of 2 years than angiography-guided PCI.
Matthias Lutz retweeted
It was a great meeting & I come away with a renewed commitment to simplify adoption, with standardised protocols/algorithms & enhanced patient outcomes @nicolasamabile Jan Kanovsky & Tom Adriaenssens. Thanks @BooneEls and the @AbbottCardio team for enabling
Matthias Lutz retweeted
Sharing a discussion point from one of our INOCA International Medical Advisory Board members.
This is also posted for discussion in our Doctors Only INOCA Case Discussion group.
If you would like to join just click on the link to request membership! Medshr.it/INOCA
Matthias Lutz retweeted
And to close the session: 5 Years Follow-up of the FANTOM II trial: study for which CERC was in charge of the monitoring activities in France @PCRonline @mjlutz #EuroPCR @mc_morice #interventionalcardiology #clinicaltrials #clinicalstudies
Matthias Lutz retweeted
Thank you for putting this together @thiele_holger
However:
I think you just chose to use the number of citations within the last 5 years. Normally ALL citations and ALL followers are considered. Thoughts?!
@mmamas1973 @drjohnm @TRassafMD @JBauersachsMD @iamritu @EricTopol
Matthias Lutz retweeted
@GhanemAlexander @DrThomasSchmitz @m_leistner @KardiologieHH @kaschenke @MoritzSeiffert @HolgerNef @TSchneider0 @FabianGocht @sulimov_dmitry @Obisht @MJLutz @EPTIG @felixmeincke @doc_cardio @YoungDgk @SiiloMessenger
Matthias Lutz retweeted
We tend not to shout about what we do at INOCA International, we just get on and do it to the best of our ability to benefit INOCA patients everywhere.
Thank you to all our fantastic Twitter supporters who continually help us to improve understanding of INOCA around the world!🙏
Matthias Lutz retweeted
Wow! A huge Thank You to all our Twitter friends and supporters! In less than a week, over 1,000 additional views of our video - now over 4,000 views!
Thank you so much for all your help and support!
The more we all raise awareness the more we can help patients - Thank You! 🙏
Matthias Lutz retweeted
Discover what success looks like in imaging vs angiography-led PCI and how imaging has been used to maximise successful stent implantation.
Matthias Lutz retweeted
Ganz im Stillen hat sich im Restaurant Pastis in #Kiel ein Betreiberwechsel vollzogen. Seit August wird das auch als „Wohnzimmer Düsternbrooks“ bezeichnete Lokal von dem Koch Lars Fauk und seinem Schwager Nicolas Wendelken geführt. kn-online.de/Kiel/Kieler-Res…
But you are also right. The Encore is that one from @revamedicalinc Fantom Encore. Already CE-marked and 95 micron struts. First 5 years results @TCTConference next week.
Final poll results (767 responses). More than two-thirds want to see coronary BRS investigated again. Major comments included need for implantation under IV imaging guidance and their study in adequate RCTs with long-term FU. [Auto-spell error: device is Esprit not Encore]
1
2
It’s so true!! My hometown 🤩
Simply the bescht: #Freiburg schafft es beim „Lonely Planet“ in die Top drei der Reiseziele weltweit. Völlig zu Recht, findet @Nadeschda78 in der SZ-Kolumne #BesterDinge. sz.de/1.5451329?utm_source=T…
Matthias Lutz retweeted
Freiburg im Breisgau hat es in die Auswahl der Top-Reiseziele des »Lonely Planet« geschafft. Die Begründung liest sich wie eine Liebeserklärung. spiegel.de/reise/lonely-plan…
Matthias Lutz retweeted
Abbott Encore bioresorbable scaffold is 95 um thick - not much thicker than DES. Given ongoing late risk from metallic DES (~2%/year for at least 10 years), is it time to start re-studying coronary BRS?
68%Yes, absolutely
32%No, not needed
767 votes • Final resultsGood Long-term Results With FANTOM #BRS , but More Data Needed tctmd.com/news/good-long-ter… @ziadalinyc @SVRaoMD @GreggWStone @swissCTO @HolgerNef @m_leistner @KPujdak @bbraun_de @tommasoggori




























